Vitalhub Corp. (TSE:VHI - Get Free Report) shares fell 3.4% on Monday . The stock traded as low as C$10.44 and last traded at C$10.68. 173,173 shares traded hands during trading, an increase of 31% from the average session volume of 132,698 shares. The stock had previously closed at C$11.06.
Analyst Upgrades and Downgrades
Several research analysts have commented on the company. Raymond James set a C$13.50 target price on Vitalhub and gave the stock an "outperform" rating in a research note on Thursday, March 27th. TD Securities increased their price target on Vitalhub from C$13.00 to C$14.00 and gave the stock a "buy" rating in a report on Monday, March 31st. Finally, Scotiabank set a C$14.00 price objective on shares of Vitalhub and gave the stock an "outperform" rating in a report on Thursday, January 30th. Four equities research analysts have rated the stock with a buy rating, According to MarketBeat.com, the company presently has a consensus rating of "Buy" and an average price target of C$12.90.
Check Out Our Latest Stock Analysis on VHI
Vitalhub Price Performance
The stock has a market capitalization of C$551.74 million, a PE ratio of 165.90, a PEG ratio of 1.18 and a beta of 1.26. The company has a 50 day moving average price of C$10.04 and a 200-day moving average price of C$10.66.
Insiders Place Their Bets
In other Vitalhub news, Director Francis Nelson Shen purchased 25,000 shares of the stock in a transaction dated Friday, May 16th. The shares were purchased at an average cost of C$10.23 per share, with a total value of C$255,750.00. Corporate insiders own 18.57% of the company's stock.
Vitalhub Company Profile
(
Get Free Report)
Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.
Featured Stories
Before you consider Vitalhub, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vitalhub wasn't on the list.
While Vitalhub currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
